| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |